Trial Profile

Phase III trial of tesofensine in patients with obesity (trial 2)

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 25 Feb 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tesofensine (Primary)
Indications Obesity
Focus Registrational; Therapeutic Use

Most Recent Events

18 Feb 2016 According to a Saniona media release, this trial is expected to initiate in late 2016.
31 May 2011 New trial record
26 May 2011 The design of the pivotal phase III programme for tesofensine was revised based on feedback from the US FDA and the EMA.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com